Havn Life Sciences Ivan Casselman Casselman

Havn Life Sciences chief psychedelic officer marries love of plants with desire to help

Dr. Ivan Casselman says he has been setting himself up to work in the psychedelic industry for quite some time.


Canndescent CEO Adrian Sedlin hosts free webinar October 19

A 1998 graduate of Harvard Business School, Sedlin left early retirement in 2015 to launch Canndescent

Kamala Kamala Harris market cap billion

Market cap madness—cannabis investors enjoy the highs after Kamala Harris promises decriminalization

The Democratic vice presidential nominee has shown that her words can move markets.


For SpeakEasy’s Marc Geen, growing cannabis carries on a family farming tradition

It may be a new world, but Geen chose a moniker that looks back to an earlier, less enlightened time

investors cannabis investors stock price

Up in Smoke best describes what happened to cannabis investors this week

Aurora Cannabis shares have been pummelled since the start of the year; over the same period, Tilray stock has fared nearly as badly.

Aurora Cannabis Aurora Aurora shares weed company

Aurora Cannabis shares plunge by 29 percent; other weed stocks also decline

Canopy Growth Corp. is now worth nine times as much as the Edmonton-based weed company.